An Aggressive Presentation of Merkel Cell Carcinoma: A Case Report

被引：1
作者：
Ines, Zemni [1 ]
Sabrine, Haddad [1 ]
Saadallah, Fatma [1 ]
Mohamed Ali, Ayadi [1 ]
Lamia, Charfi [1 ]
Riadh, Chargui [1 ]
Khaled, Rahal [1 ]
机构：
[1] Univ Tunis El Manar, Salah Azaiez Inst, Tunis, Tunisia
来源：
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS | 2020年 / 8卷
关键词：
Merkel cell carcinoma; neuroendocrine; surgery; systemic treatment; RADIOTHERAPY; MANAGEMENT; DIAGNOSIS;
D O I：
10.1177/2324709620963714
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Merkel cell carcinoma (MCC) is a rare malignant neuroendocrine tumor more common in immunosuppressed old patients. It is characterized by a high frequency of local recurrence, regional nodal metastasis, distant metastasis, and low survival rate. The diagnosis of MCC is challenging due to its rarity and can be clinically mistaken for other skin cancer. We report a case of locally advanced MCC of the left groin with aggressive behavior that was finally controlled with a combined treatment and we collected data from the literature to discuss the appropriate therapeutic algorithm for the management of this uncommon skin tumor.
引用
收藏
页数：4
相关论文
共 14 条
  • [1] Merkel Cell Carcinoma, Version 1.2018 Clinical Practice Guidelines in Oncology
    Bichakjian, Christopher K.
    Olencki, Thomas
    Aasi, Sumaira Z.
    Alam, Murad
    Andersen, James S.
    Blitzblau, Rachel
    Bowen, Glen M.
    Contreras, Carlo M.
    Daniels, Gregory A.
    Decker, Roy
    Farma, Jeffrey M.
    Fisher, Kris
    Gastman, Brian
    Ghosh, Karthik
    Grekin, Roy C.
    Grossman, Kenneth
    Ho, Alan L.
    Lewis, Karl D.
    Loss, Manisha
    Lydiatt, Daniel D.
    Messina, Jane
    Nehal, Kishwer S.
    Nghiem, Paul
    Puzanov, Igor
    Schmults, Chrysalyne D.
    Shaha, Ashok R.
    Thomas, Valencia
    Xu, Yaohui G.
    Zic, John A.
    Hoffmann, Karin G.
    Engh, Anita M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (06): : 742 - 774
  • [2] Radiation Versus Resection for Merkel Cell Carcinoma
    Bichakjian, Christopher K.
    Coit, Daniel G.
    Wong, Sandra L.
    [J]. CANCER, 2010, 116 (07) : 1620 - 1622
  • [3] Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma A Preplanned Interim Analysis of a Clinical Trial
    D'Angelo, Sandra P.
    Russell, Jeffery
    Lebbe, Celeste
    Chmielowski, Bartosz
    Gambichler, Thilo
    Grob, Jean-Jacques
    Kiecker, Felix
    Rabinowits, Guilherme
    Terheyden, Patrick
    Zwiener, Isabella
    Bajars, Marcis
    Hennessy, Meliessa
    Kaufman, Howard L.
    [J]. JAMA ONCOLOGY, 2018, 4 (09)
  • [4] Recurrence and Survival in Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: Analysis of 153 Patients from a Single Institution
    Fields, Ryan C.
    Busam, Klaus J.
    Chou, Joanne F.
    Panageas, Katherine S.
    Pulitzer, Melissa P.
    Kraus, Dennis H.
    Brady, Mary S.
    Coit, Daniel G.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (09) : 2529 - 2537
  • [5] Radiotherapy in the Multidisciplinary Management of Merkel Cell Carcinoma
    Green, Michael D.
    Hayman, James A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (06): : 776 - 781
  • [6] Merkel cell carcinoma: Changing incidence trends
    Hodgson, NC
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (01) : 1 - 4
  • [7] Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
    Jouary, T.
    Leyral, C.
    Dreno, B.
    Doussau, A.
    Sassolas, B.
    Beylot-Barry, M.
    Renaud-Vilmer, C.
    Guillot, B.
    Bernard, P.
    Lok, C.
    Bedane, C.
    Cambazard, F.
    Misery, L.
    Esteve, E.
    Dalac, S.
    Machet, L.
    Grange, F.
    Young, P.
    Granel-Brocard, F.
    Truchetet, F.
    Vergier, B.
    Delaunay, M. M.
    Grob, J. J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (04) : 1074 - 1080
  • [8] Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥ 1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
    Kaufman, Howard L.
    Russell, Jeffery S.
    Hamid, Omid
    Bhatia, Shailender
    Terheyden, Patrick
    D'Angelo, Sandra P.
    Shih, Kent C.
    Lebbe, Celeste
    Milella, Michele
    Brownell, Isaac
    Lewis, Karl D.
    Lorch, Jochen H.
    von Heydebreck, Anja
    Hennessy, Meliessa
    Nghiem, Paul
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [9] Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
    Lebbe, Celeste
    Becker, Juergen C.
    Grob, Jean-Jacques
    Malvehy, Josep
    del Marmol, Veronique
    Pehamberger, Hubert
    Peris, Ketty
    Saiag, Philippe
    Middleton, Mark R.
    Bastholt, Lars
    Testori, Alessandro
    Stratigos, Alexander
    Garbe, Claus
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2396 - 2403
  • [10] Rising incidence of Merkel cell carcinoma
    Lyhne, Dorte
    Lock-Andersen, Jorgen
    Dahlstrom, Karin
    Drzewiecki, K. T.
    Balslev, Eva
    Muhic, Aida
    Krarup-Hansen, Anders
    [J]. JOURNAL OF PLASTIC SURGERY AND HAND SURGERY, 2011, 45 (06) : 274 - 280
12